Fax: (713) 563-2331
Hodgkin lymphoma involving extranodal and nodal head and neck sites
Characteristics and outcomes
Article first published online: 17 MAY 2010
Copyright © 2010 American Cancer Society
Volume 116, Issue 16, pages 3825–3829, 15 August 2010
How to Cite
Iyengar, P., Mazloom, A., Shihadeh, F., Berjawi, G. and Dabaja, B. (2010), Hodgkin lymphoma involving extranodal and nodal head and neck sites. Cancer, 116: 3825–3829. doi: 10.1002/cncr.25138
- Issue published online: 4 AUG 2010
- Article first published online: 17 MAY 2010
- Manuscript Accepted: 10 NOV 2009
- Manuscript Revised: 1 OCT 2009
- Manuscript Received: 20 AUG 2009
- Hodgkin lymphoma;
- head and neck;
- external beam radiation;
Most Hodgkin lymphoma (HL) patients present with disease in nodal regions. However, in a small subset, disease develops in unique anatomic sites such as the head and neck area. This study aims to identify the characteristics and outcomes of patients who develop HL involving extranodal and nodal head and neck sites.
The authors searched The University of Texas M. D. Anderson Cancer Center's database for HL patients treated between 1967 and 2007 and included those with HL at head and neck sites. They reviewed the records for site of involvement, pathology, treatment, and survival.
The authors identified 39 patients with extranodal and nodal HL of the head and neck. Five patients with lymphocyte predominant HL were excluded. Specifically, 10 of 34 patients had disease in the tonsils, 9 in the nasopharynx, 8 in the thyroid, 3 in the parotid, 2 in the adenoids, and 1 each in Waldeyer's ring and nasal antrum. Median age at diagnosis was 31.5 years, average age at diagnosis was 38 years, and 22 of 34 were male; 23 had stage I or II disease. Pathologically, 14 of 34 had the nodular sclerosis subtype, whereas 15 had mixed cellularity. Twenty-nine of 34 had nodal neck disease at presentation. Five of 34 received chemotherapy alone, 5 received radiation alone, and 24 received combination therapy. Twenty-one of 34 received 39.6 gray of external beam radiation. The most commonly used chemotherapy regimens were ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and MOPP (mechlorethamine, vincristine, procarbazine, and prednisone). At last follow-up, 85% were disease-free.
HL of the head and neck is primarily diagnosed as early stage disease of men and of young to middle-aged individuals. Chemotherapy and primary/adjuvant radiotherapy offer excellent local and systemic control. The extent to which nodal disease is present in the neck does not alter outcomes when combined modality therapy is offered. Despite the unique anatomic location of these lesions, standard HL protocols work effectively to promote disease-free survival. Cancer 2010. © 2010 American Cancer Society.